| Line Item | 2025-10-03 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $548.9M | -2.8% | +8.6% |
| Cost of Revenue | $220.0M | -4.3% | +0.6% |
| Gross Profit | $328.9M | -1.7% | +14.8% |
| R&D Expense | $29.7M | -3.1% | +45.1% |
| SG&A Expense | $263.6M | -1.3% | +5.5% |
| Operating Income | -$558.5M | -3225.1% | -1659.7% |
| Interest Expense | $8.8M |
| Line Item | 2025-10-03 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $33.6M | -23.7% | -5.1% |
| Accounts Receivable | $431.8M | -4.8% | +7.9% |
| Inventory | $613.8M | -2.3% | +0.7% |
| Current Assets | $1.28B | -0.0% | +6.4% |
| Total Assets | $4.43B | -11.7% | -20.1% |
| Current Liabilities |
| Line Item | 2025-10-03 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $128.7M | — | — |
| Capital Expenditures | $141.1M | — | — |
| Investing Cash Flow | -$166.4M | — | — |
| Financing Cash Flow | $20.5M | — | — |
| Free Cash Flow | -$12.4M | — | — |
| -5.0% |
| -20.2% |
| Pre-tax Income | -$566.9M | -2109.7% | -1230.6% |
| Income Tax | $4.0M | -62.9% | +144.0% |
| Net Income | -$571.1M | -1454.6% | -1712.0% |
| EPS (Basic) | -$9.99 | -1460.9% | -1622.4% |
| EPS (Diluted) | -$9.99 | -1460.9% | -1622.4% |
| $575.4M |
| +1.3% |
| +8.5% |
| Long-term Debt | $1.36B | -2.4% | +1.0% |
| Total Liabilities | $2.41B | -1.3% | +8.7% |
| Stockholders' Equity | $2.02B | -21.6% | -39.3% |